Profound Medical Reports Strong First Quarter 2026 Financial Results
Profound Medical Corp. reported a 104% revenue growth in Q1 2026, reaching approximately $5.3 million. The company improved its operating performance with reduced expenses and a gross margin of 72%. They announced that Humana is now covering the TULSA Procedure and set a revenue outlook of $25 million for the full year, projecting a 56% increase compared to the previous year.
– Quarterly results marked by 104% revenue growth and improved operating performance –